Water → N-(5-Chloro-2-methylphenyl)-4-{4-[5-(2-formylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidine-1-carboxamide

HRID 1469224노트

반응식

HRID 1469224 반응식
Cl.[NH:2]1[CH2:7][CH2:6][CH:5]([C:8]2[S:9][CH:10]=[C:11]([C:13]3[CH2:17][CH:16]([C:18]4[CH:25]=[CH:24][CH:23]=[CH:22][C:19]=4[CH:20]=[O:21])[O:15][N:14]=3)[N:12]=2)[CH2:4][CH2:3]1.[Cl:26][C:27]1[CH:32]=[CH:31][C:30]([CH3:33])=[C:29]([N:34]=[C:35]=[O:36])[CH:28]=1.O>ClCCl.C(N(C(C)C)CC)(C)C.N12CCCN=C1CCCCC2>[Cl:26][C:27]1[CH:32]=[CH:31][C:30]([CH3:33])=[C:29]([NH:34][C:35]([N:2]2[CH2:3][CH2:4][CH:5]([C:8]3[S:9][CH:10]=[C:11]([C:13]4[CH2:17][CH:16]([C:18]5[CH:25]=[CH:24][CH:23]=[CH:22][C:19]=5[CH:20]=[O:21])[O:15][N:14]=4)[N:12]=3)[CH2:6][CH2:7]2)=[O:36])[CH:28]=1

참가 물질

7

실험 절차

To a suspension of 2-{3-[2-(piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}benzaldehyde hydrochloride (1.43 g) in dichloromethane (30 ml) and diisopropylethylamine (0.73 ml) were added, at room temperature, 4-chloro-2-isocyanato-1-methylbenzene (700 mg) and one drop of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). The mixture was stirred at room temperature overnight, and water was then added. The aqueous phase was removed and extracted with ethyl acetate. The combined organic phases were dried over sodium sulphate and concentrated under reduced pressure. The residue was purified by chromatography. This gave N-(5-chloro-2-methylphenyl)-4-{4-[5-(2-formylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidine-1-carboxamide (1.23 g).

후처리

  1. additionwere added, at room temperature
  2. customThe aqueous phase was removed
  3. extractionextracted with ethyl acetate
  4. dry with materialThe combined organic phases were dried over sodium sulphate
  5. concentrationconcentrated under reduced pressure
  6. customThe residue was purified by chromatography

출처 및 근거

ORD 기록
ord-9942e7d385704c3cb69d1bdecb6f6b4b
출처 데이터셋
uspto-grants-2015_04
특허 번호
US09006266B2

반응 노트

불러오는 중…